The 6-Layer Decision Architecture

Market and Category Strategy

Define the market you will own and the category position that drives adoption. This layer sequences competitive positioning, care-setting priorities, and buyer pathway identification before capital is committed to launch. The goal is a defensible market thesis that aligns clinical utility with procurement logic.

Key Deliverables

• Addressable market sizing and care-setting prioritization

• Competitive landscape mapping and positioning architecture

• Category creation or category entry strategy

• Buyer persona development and decision-maker mapping

Evidence and Adoption Strategy

Align clinical and economic data to payer and physician decision criteria. FDA clearance proves the test works (validity), but payers require proof that the test changes patient outcomes (utility). This layer closes the evidence gap by designing studies and data packages that satisfy both clinical and economic stakeholders.

Key Deliverables

• Clinical utility mapping for formulary and coverage discussions

• Economic value narrative development for procurement

• Evidence gap analysis: validity vs. utility requirements

• KOL strategy and publication planning for clinical adoption

Channel and Distribution Architecture

Design the distribution pathway that matches your product to its buyer. Channel selection in diagnostics is not a distribution decision: it is an architecture decision. The wrong channel can permanently constrain margin, limit geographic reach, and create dependency structures that become impossible to unwind.

Key Deliverables

• Channel evaluation framework (direct, distribution, hybrid)

• Distributor selection criteria and margin architecture

• GPO/IDN access strategy and contract positioning

• Channel governance and performance measurement systems

Reimbursement and Access Strategy

Build the coverage and coding foundation that unlocks sustainable revenue. Without reimbursement infrastructure, even clinically superior diagnostics cannot sustain adoption beyond pilot programs. This layer sequences CPT/PLA coding strategy, coverage policy development, and payer engagement to compress the path from clearance to contracted revenue.

Key Deliverables

• CPT/PLA coding pathway analysis and submission strategy

• Coverage policy development and LCD/NCD engagement

• Payer evidence package design and health economics modeling

• Prior authorization workflow design and appeals architecture

Launch Sequencing and Field Strategy

Stage market entry so every resource compounds toward early traction. Launch sequencing is not a timeline: it is a capital allocation decision. This layer determines which geographies, accounts, and evidence milestones are activated first, and in what order, to maximize the probability of self-sustaining adoption momentum.

Key Deliverables

• Launch sequencing roadmap with milestone gates

• Territory design and account prioritization framework

• Sales enablement toolkit: ROI calculators, objection handling, clinical briefs

• Pilot-to-scale conversion playbook

Stakeholder and Investor Alignment

Ensure your commercial story holds up to diligence from funders and partners. Investors evaluate diagnostic companies on commercial architecture, not clinical promise. This layer structures the investor narrative, board reporting cadence, and milestone framework that converts scientific progress into investable commercial traction.

Key Deliverables

• Investor-grade commercial narrative and diligence materials

• Board reporting framework tied to adoption metrics

• Milestone architecture linking funding rounds to commercial proof points

• Strategic partnership positioning and term sheet preparation